Profitability Metrics

Gross Margin
90.36%
Operating Margin
124.29%
Net Margin
99.38%

Efficiency Metrics

Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
124.29%
Income Tax Rate
0.00%
EPS
2.6900000000

Balance Sheet Analysis

Current Ratio
21.55
Cash Ratio
21.55
Working Capital
$10.44M
Debt to Equity
0.51
Debt to Assets
33.55%
Equity Ratio
65.57%

Cash Flow Analysis

Operating Cash Flow Ratio
66.44%
Free Cash Flow Ratio
66.44%
CapEx to Revenue
0.00%
Dividends Paid
$26.79M
Stock Buybacks
No buybacks
Total Shareholder Returns
$26.79M
Cash Position Change
116,428,471.4%

Key Takeaways (2024 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
114.02%
Net Income
285.42%
EPS
285.52%
Operating Income
481.88%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
12.38%
Operating Cash Flow
54.22%
Free Cash Flow
54.22%

Balance Sheet Health

Assets
3.35%
Debt
-5.70%
Book Value per Share
8.21%
Inventory
0.00%

Shareholder Returns

Dividends per Share
-16.10%
Shares Outstanding
0.00%

Long Term Trends

3Y Revenue/Share
-39.96%
5Y Revenue/Share
40.76%
3Y Dividend/Share
-24.56%
5Y Dividend/Share
-27.66%